1. Home
  2. ACRS vs NWFL Comparison

ACRS vs NWFL Comparison

Compare ACRS & NWFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aclaris Therapeutics Inc.

ACRS

Aclaris Therapeutics Inc.

HOLD

Current Price

$4.52

Market Cap

314.2M

Sector

Health Care

ML Signal

HOLD

Logo Norwood Financial Corp.

NWFL

Norwood Financial Corp.

HOLD

Current Price

$27.70

Market Cap

277.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACRS
NWFL
Founded
2012
1870
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
314.2M
277.5M
IPO Year
2015
1998

Fundamental Metrics

Financial Performance
Metric
ACRS
NWFL
Price
$4.52
$27.70
Analyst Decision
Strong Buy
Hold
Analyst Count
5
1
Target Price
$9.75
$26.50
AVG Volume (30 Days)
2.9M
37.2K
Earning Date
02-26-2026
01-22-2026
Dividend Yield
N/A
4.60%
EPS Growth
N/A
N/A
EPS
N/A
3.01
Revenue
$15,742,000.00
$86,168,000.00
Revenue This Year
N/A
$85.58
Revenue Next Year
N/A
$29.32
P/E Ratio
N/A
$9.24
Revenue Growth
N/A
78.16
52 Week Low
$1.05
$21.25
52 Week High
$4.89
$30.59

Technical Indicators

Market Signals
Indicator
ACRS
NWFL
Relative Strength Index (RSI) 80.02 41.21
Support Level $2.61 $27.60
Resistance Level $4.89 $29.58
Average True Range (ATR) 0.38 0.78
MACD 0.21 -0.03
Stochastic Oscillator 84.37 0.00

Price Performance

Historical Comparison
ACRS
NWFL

About ACRS Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.

About NWFL Norwood Financial Corp.

Norwood Financial Corp is a U.S.-based bank holding company. It offers various personal and business credit services, trust and investment products, and real estate settlement services to consumers, businesses, nonprofit organizations, and municipalities in each of the communities that the bank serves. The bank also manages automated teller machines at its branch location. It serves the Pennsylvanian counties of Wayne, Pike, Monroe, and Lackawanna, as well as Susquehanna County.

Share on Social Networks: